Holdings: Exploratory Study on Active Pharmaceutical Ingredient Manufacturing for Essential Medicines

Exploratory Study on Active Pharmaceutical Ingredient Manufacturing for Essential Medicines

Active Pharmaceutical Ingredients (API) of good quality is core to the manufacturing of effective and safe essential drugs. The price of APIs is the main cost driver for manufacturing. Only a limited number of large manufacturers of finished pharma...

Full description

Bibliographic Details
Main Authors:	Bumpas, Janet, Betsch, Ekkehard
Language:	English en_US
Published:	World Bank, Washington, DC 2013
Subjects:	ACTIVE INGREDIENTS ACTIVITIES ADVERTISING ANALGESICS ANTIBIOTICS ANTIMALARIALS AUDITS BARRIER TO ENTRY BARRIERS TO ENTRY BID BRAND BRANDS BROKERS BUDGET CAPACITY BUILDING CAPITAL BASES CAPITAL INVESTMENT CAPITAL REQUIREMENT CAPITAL REQUIREMENTS CAPSULES CERTIFICATION CHECKS CHILDREN CHLOROQUINE RESISTANCE CHRONIC DISEASES COMMERCIAL MARKETS COMMODITIES COMMON MARKET COMPANIES COMPANY COMPETITION COMPETITIVE MARKETS COMPETITIVENESS COMPETITORS CONTAMINATION CONTESTABILITY CONTRACT CONTRACTS CORPORATION COUNTRY RISK COURSE OF THERAPY CURRENCY DEMAND DEMAND FORECASTING DEPRECIATION DERIVATIVES DEVELOPING COUNTRIES DEVELOPING COUNTRY DIFFERENTIAL PRICING DIRECT COSTS DOMINANT FIRMS DONOR DONOR FINANCING DONORS DRUG EVALUATION DRUG MARKETS DUE DILIGENCE EFFICIENT MARKET ENTERPRISE EQUIPMENT ESSENTIAL DRUGS EXCHANGE EXCHANGE RATES EXPANSION EXPORT MARKETS EXPORTERS FAIR FAIR PRICE FINANCING FINISHED PRODUCT FIRM FIRMS FOREIGN CURRENCY FUTURE GENERIC DRUGS GLOBAL ECONOMY GLOBAL MARKET GMP GOOD GOOD MANUFACTURING PRACTICES GOODS GRANT HEALTH CARE HUMAN DEVELOPMENT IMMUNIZATION INTELLECTUAL PROPERTY INTELLECTUAL PROPERTY RIGHTS INTERFERON INTERNATIONAL BANK INTERNATIONAL COMMERCE INTERNATIONAL FINANCE INTERNATIONAL MARKET INTERNATIONAL STANDARDS INVESTING INVESTMENT ISONIAZID LABORATORIES LACK OF TRANSPARENCY LAWS LEGAL COUNSEL LOCAL GOVERNMENT LOCAL MANUFACTURERS LOCAL MARKET MANUFACTURER MANUFACTURERS MARKET MARKET ECONOMY MARKET ENTRY MARKET INFORMATION MARKET PRICE MARKET PRICES MARKET SEGMENT MARKET SHARE MARKET SHARES MARKET SIZE MARKET STRUCTURES MARKET TRANSPARENCY MARKETING MARKETPLACE MARKETS MEDICINE MNC MONITORING MULTINATIONAL MULTINATIONAL CORPORATION OIL PRICES OPEN MARKET OPTION OPTIONS PACKAGING PARTIES PARTNER PARTNERS PAYMENT TERMS PHARMACEUTICAL PHARMACEUTICAL INDUSTRY PHARMACEUTICAL INSPECTION PHARMACEUTICAL MANUFACTURERS PHARMACEUTICAL MANUFACTURING PHARMACEUTICAL PRODUCTION PHARMACEUTICAL PRODUCTS PHARMACEUTICAL SECTOR PHARMACEUTICAL TECHNOLOGY PHARMACEUTICALS PHARMACY PLANNING PLEDGES POOLED PROCUREMENT PORTFOLIO PORTFOLIO MANAGEMENT PREDATORY PRICING PREPAYMENT PRICE PRICE COMPETITION PRICE QUOTATIONS PRICE VOLATILITY PRICES PRICING PRICING SCHEMES PROCUREMENT PRODUCT PRODUCT QUALITY PRODUCTS PROFIT PROFIT MARGIN PROFIT MARGINS PUBLIC HEALTH PURCHASING QUALITY ASSURANCE QUININE REGULATORY AUTHORITIES REGULATORY AUTHORITY REGULATORY CAPACITY REGULATORY STANDARDS RETURN REVENUES SALES SECURITY SEE STATE OWNED ENTERPRISES STORE SUPPLIER SUPPLIERS SUPPLY SUPPLY CHAIN SUPPLY CHAIN MANAGEMENT TABLETS TARGET MARKET TECHNICAL ASSISTANCE TECHNICAL SUPPORT TENDERING TRADING TRANSACTION TRANSACTION COSTS TRANSACTIONS TRANSFER PRICE VACCINES VALUE WORKING CAPITAL WORLD MARKET
Online Access:	http://documents.worldbank.org/curated/en/2009/09/11809103/exploratory-study-active-pharmaceutical-ingredient-manufacturing-essential-medicines http://hdl.handle.net/10986/13682

Internet

http://documents.worldbank.org/curated/en/2009/09/11809103/exploratory-study-active-pharmaceutical-ingredient-manufacturing-essential-medicines
http://hdl.handle.net/10986/13682

Exploratory Study on Active Pharmaceutical Ingredient Manufacturing for Essential Medicines

Internet

Similar Items